**Insider Trading Summary: Inhibrx Biosciences and Alpha Metallurgical Resources**
On Tuesday, September 9, 2023, Inhibrx Biosciences CEO Mark Lappe purchased 25,000 shares at $105.82 each, totaling an investment of $2.65 million. Following this transaction, the stock saw an increase of approximately 11.1%, reaching a trading high of $128.54, resulting in a gain of about 21.5% for Lappe.
Similarly, Alpha Metallurgical Resources Director Kenneth S. Courtis bought 10,000 shares at $225.83 each, amounting to $2.26 million. Courtis has previously invested a total of $54.40 million in 14 prior purchases over the past year at an average cost of $173.82 per share. As of Wednesday, the stock is up 2.2%, with a trading high of $231.77, yielding a gain of approximately 2.6% on Courtis’ latest purchase.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
